Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 3 - You Need To See This

Johnson & Johnson to stop selling talc-based powder after cancer lawsuits

Lawsuits have claimed product contains asbestos and causes cancer which company denies

Evening Standard

3 Dividend-Paying Stocks to Consider During a Recession

Rising inflation, the Fed’s hawkish stance to tame it, and an economic contraction for two consecutive quarters have stoked fears of a recession in the U.S. economy. Amid the likely economic downturn, investors could consider investing in stocks that provide a steady income in the form of dividends. Therefore, we…

StockNews.com

4 Outperforming Stocks for People Who Hate Volatility

The stock market has been experiencing immense volatility lately as investors remain concerned over the multi-decade high inflation and the Fed’s aggressive interest rates to control it. However, fundamentally sound stocks Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), KT Corporation (KT), and Weis Markets (WMK) are outperforming the broader market.…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Mark Walters, Daniel Finkelstein and Barbara Charone - Who are Chelsea's board of directors?

Chelsea have confirmed members of their new board following the planned departures of Marina Granovskaia and Bruce Buck

Football London

5 Durable Stocks to Strengthen Your Portfolio

Given the current market turmoil caused due to surging inflation and the Fed’s aggressive interest rate hikes to bring prices down, it could be wise to invest in stocks that do not fluctuate significantly in adverse market conditions. The solid stability of Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), Marubeni…

StockNews.com

Column: End of Howard Johnson era brings back ice cream memories

An era is over. We have come to the end of the road.

St. Louis Post-Dispatch

A year on, Quad initiative for 1 billion India-made vaccines runs into rough weather

Production of Johnson & Johnson jab at Hyderabad-based firm’s facility stalled over indemnity and safety issues

The Hindu

Read news from The Economist, FT, and more,
with one subscription

FDA limits use of Johnson & Johnson COVID vaccine over blood clot risks, agency says

The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5.

McClatchy Washington Bureau

FDA limits Johnson & Johnson's COVID vaccine to some people due to blood clot risk

The chances of dying following after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.

WEKU

New Zealand travel: Everything you need to know as country opens to British tourists from 1 May

After more than two years, tourists can finally return

The Independent UK

COVID-19 vaccination | Debate on over efficacy of booster doses

Booster or natural infection will reduce the chance of another infection for just a few months, they say.

The Hindu

Hairdresser in agony suffering severe allergic reaction after using baby shampoo

Luke Tyrell had to take anti-inflammatory medication after the Johnson's Baby Shampoo Gold left him with intense pain that he likened to pouring 'acid' on his skin.

Daily Record

Hairdresser suffers pain 'like acid on skin' after using baby shampoo

Luke Tyrel, from Clitheroe, had to take anti-inflammatory medication after the Johnson’s Baby Shampoo Gold left him with intense pain down his neck and throat for an hour

Daily Mirror

Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?

Johnson & Johnson (NYSE: JNJ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for th

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.